intensity modulated external beam radiation therapy

PROCEDURE2 trials

Sponsors

British Columbia Cancer Agency, Virginia Commonwealth University

Conditions

Adenocarcinoma of the ProstateProstate CancerStage I Prostate CancerStage II Prostate CancerStage III Prostate CancerStage IV Prostate Cancer

Unknown Phase

Intensity Modulated Versus Interstitial - Radiation Therapy

British Columbia Cancer AgencyProstate Cancer

Start: 2007-03-31End: 2020-03-31Target: 50Updated: 2018-07-13

Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer

CompletedNCT01117935

Virginia Commonwealth UniversityAdenocarcinoma of the Prostate, Stage III Prostate Cancer, Stage II Prostate Cancer +2

Start: 2010-05-30End: 2019-03-01Updated: 2019-06-28

Related Papers

Moderately Hypofractionated Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results From a Prospective Phase I/II Trial

Frontiers in Oncology2020-08-214 citations

Five-year results from a phase I/II study of moderately hypofractionated intensity-modulated radiation therapy (IMRT) for localized prostate cancer including simultaneously integrated boost and pelvic lymph node (LN) coverage.

Journal of Clinical Oncology2020-02-19

Phase I/II study of hypofractionated intensity modulated radiotherapy (IMRT) for prostate cancer including simultaneously integrated boost (SIB).

Journal of Clinical Oncology2016-01-10